NL-OMON51134尚未招募不适用
Immune profiling of tumor and blood of patients with nasopharyngeal cancer - IM-NPC
Select0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age >=18 years
- •Able to understand the written information and able to give informed consent
- •Should have histologically confirmed NPC
- •Planned treatment with CR for locoregionally advanced NPC
排除标准
- •Unable to draw blood for study purposes
- •Any coexisting condition which needs immediate treatment and which might
- •affect the results of the study
研究者
相似试验
招募中
不适用
Analyses of immune status in cancer patientsMalignant tumorJPRN-UMIN000040469Chiba Cancer Center150
已完成
不适用
Analysis of tumor antigen and immune response using clinical samplescancer patients and healthy volunteerJPRN-UMIN000014008Mie University300
尚未招募
不适用
Analysis of patients treated with novel therapeutic agents for atopic dermatitisAtopic dermatitisJPRN-UMIN000044388Kindai University Hospital20
已完成
不适用
Evaluation of the immune-profiling for patients participating in Phase Ib/II Study of BBI608 in Combination with Pembrolizumab and the relationship between the immune-profiling and efficacy using paired biopsies and peripheral blood.metastatic colorectal cancerJPRN-UMIN000024500ational Cancer Center Hospital East59
已完成
不适用
Characterization of the immune response in patients with urothelial cell carcinoma of the bladder and during the BCG immunotherapy of bladder cancerC67Malignant neoplasm of bladderDRKS00003700Chirurgische Universitätsklinik, Abteilung für Urologie410